MPZL1/PZR, a novel candidate predisposing schizophrenia in Han Chinese

Molecular Psychiatry

Volumn 11, Issue 8, 2006, Pages 748-751

  He, G ^a,b   Liu, X ^a,b   Qin, W ^a,b   Chen, Q ^a,b   Wang, X ^a,b   Yang, Y ^a,b   Zhou, J ^a,b   Xu, Y ^c   Gu, N ^c   Feng, G ^c   Sang, H ^d   Wang, P ^e   He, L ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

^d Changchun Kaixuan Hospital   (China)

^e Wuhu No 4 People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MYELIN PROTEIN; MYELIN PROTEIN ZERO LIKE 1; UNCLASSIFIED DRUG;

ARTICLE; CHINESE; CHROMOSOME 1Q; ETHNIC GROUP; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MPZL1 PZR GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MALE; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 33746500690     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001841     Document Type: Article

References (24)

1. Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003; 361: 417-419.
2. Hovatta I, Varilo T, Suvisaari J, Terwilliger JD, Ollikainen V, Arajarvi R et al. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci. Am J Hum Genet 1999; 65: 1114-1124.
3. Brzustowicz LM, Hodgkinson KA, Chow EW, Honer WG, Bassett AS. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 2000; 288: 678-682.
4. Gurling HM, Kalsi G, Brynjolfson J, Sigmundsson T, Sherrington R, Mankoo BS et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet 2001; 68: 661-673.
5. Brzustowicz LM, Hayter JE, Hodgkinson KA, Chow EW, Bassett AS. Fine mapping of the schizophrenia susceptibility locus on chromosome 1q22. Hum Hered 2002; 54: 199-209.
6. Zhao ZJ, Zhao R. Purification and cloning of PZR, a binding protein and putative physiological substrate of tyrosine phosphatase SHP-2. J Biol Chem 1998; 273: 29367-29372.
7. Zhao R, Zhao ZJ. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs. J Biol Chem 2000; 275: 5453-5459.
8. Zhao R, Zhao ZJ. Identification of a variant form of PZR lacking immunoreceptor tyrosine-based inhibitory motifs. Biochem Biophys Res Commun 2003; 303: 1028-1033.
9. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362: 798-805.
10. Little J, Bradley L, Bray MS, Clyne M, Dorman J, Ellsworth DL et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol 2002; 156: 300-310.
11. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-872.
12. Spitzer RL, Williams JB, Gibbon M, First MB. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatr 1992; 49: 624-629.
13. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 2001; 105: 145-151.
14. Germer S, Holland MJ, Higuchi R. High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res 2001; 10: 258-266.
15. Tang JX, Zhou J, Fan JB, Li XW, Shi YY, Gu NF et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatr 2003; 8: 717-718.
16. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59: 323-336.
17. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170-1177.
18. Zapata C, Carollo C, Rodriguez S. Sampling variance and distribution of the D0measure of overall gametic disequilibrium between multiallelic loci. Ann Hum Genet 2001; 65: 395-406.
19. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995; 59: 97-105.
20. Hayasaka K, Nanao K, Tahara M, Sato W, Takada G, Miura M et al. Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin. Biochem Biophys Res Commun 1991; 180: 515-518.
21. Pham-Dinh D, Fourbil Y, Blanquet F, Mattei MG, Roeckel N, Latour P et al. The major peripheral myelin protein zero gene: structure and localization in the cluster of Fc gamma receptor genes on human chromosome 1q21.3-q23. Hum Mol Genet 1993; 2: 2051-2054.
22. Hayasaka K, Himoro M, Sato W, Takada G, Uyemura K, Shimizu N et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993; 5: 31-34.
23. Hayasaka K, Himoro M, Sawaishi Y, Nanao K, Takahashi T, Takada G et al. De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III). Nat Genet 1993; 5: 266-268.
24. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746-4747.